Submission Details
| 510(k) Number | K973203 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 26, 1997 |
| Decision Date | September 30, 1998 |
| Days to Decision | 400 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K973203 is an FDA 510(k) clearance for the THYMOSTAT ELISA FOR THE DETECTION OF HUMAN IGG,M AND A ANTI-RABBIT IGG ANTIBODIES, a Complement C1q, Antigen, Antiserum, Control (Class II — Special Controls, product code DAK), submitted by Sangstat Medical Corp. (Menlo Park, US). The FDA issued a Cleared decision on September 30, 1998, 400 days after receiving the submission on August 26, 1997. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5240.
| 510(k) Number | K973203 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 26, 1997 |
| Decision Date | September 30, 1998 |
| Days to Decision | 400 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | DAK — Complement C1q, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5240 |